Literature DB >> 3137095

Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression.

D R Meldrum1, A Wisot, F Hamilton, A L Gutlay, D Huynh, W Kempton.   

Abstract

The time course of suppression of ovarian estrogen production and follicular development with leuprolide was examined in 40 normal women before ovarian stimulation for in vitro fertilization (IVF). Initiation of leuprolide during the midluteal phase caused a significantly more prompt suppression than when treatment was started during the early follicular phase (day 1). Injection of the same total amount of leuprolide in two divided doses also caused a significantly more prompt suppression. These two methods were consistent enough to make routine use of leuprolide practical before ovarian stimulation for IVF.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3137095     DOI： 10.1016/s0015-0282(16)60121-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  12 in total

1.  Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.

Authors:  M M Biljan; N G Mahutte; N Dean; R Hemmings; F Bissonnette; S L Tan
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

2.  Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.

Authors:  T J Gelety; E S Surrey
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

3.  Nocturnal Hot Flashes: Relationship to Objective Awakenings and Sleep Stage Transitions.

Authors:  Matt T Bianchi; Semmie Kim; Thania Galvan; David P White; Hadine Joffe
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

4.  Ovarian suppression with leuprolide acetate: comparison of luteal, follicular, and flare-up administration in controlled ovarian hyperstimulation for oocyte retrieval.

Authors:  P R Gindoff; J L Hall; R J Stillman
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-04

5.  Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles.

Authors:  D R Session; A H Saad; D D Salmansohn; A C Kelly
Journal:  J Assist Reprod Genet       Date:  1995-05       Impact factor: 3.412

6.  Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction.

Authors:  G E Fiszbajn; R G Lipowicz; L Elberger; A Grabia; S D Papier; S P Brugo Olmedo; C F Chillik
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

7.  Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.

Authors:  J M Cummins; J M Yovich; W R Edirisinghe; J L Yovich
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-12

8.  Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol.

Authors:  Hadine Joffe; David P White; Sybil L Crawford; Kristin E McCurnin; Nicole Economou; Stephanie Connors; Janet E Hall
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

9.  A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.

Authors:  Hadine Joffe; Sybil Crawford; Nicole Economou; Semmie Kim; Susan Regan; Janet E Hall; David White
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

10.  Serum inhibin B correlates with successful ovulation in infertile women.

Authors:  S Luisi; M Palumbo; G Calonaci; V De Leo; S Razzi; P Inaudi; G Cobellis; F Petraglia
Journal:  J Assist Reprod Genet       Date:  2003-06       Impact factor: 3.412
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.